Pillstats
Rx only · Injection, Solution · Intramuscular

Ketorolac Tromethamine

Brands: Toronova Ii Suik · Toronova Suik · Ketorolac Tromethamine

24 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US75 NDCs
24 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATC
RxCUI (US)
US makers24 labelers
Packages94
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 35 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.272$0.544$0.816$1.09Feb 2025Mar 2026Jul 2026
$0.818
Latest avg · Jul 22, 2026
-14%
Since Feb 19, 2025
24
Active US suppliers
22%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

187K374K561K748K2025 Q12025 Q22025 Q32025 Q42026 Q1
531K
Rx · 2026 Q1
665K
Units dispensed
-18%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it24 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Fresenius Kabi USA, LLCunknown14SUPPLYING
Eugia US LLCunknown7SUPPLYING
HF Acquisition Co LLC, DBA HealthFirstunknown7SUPPLYING
Hospira, Inc.unknown6SUPPLYING
Baxter Healthcare Corporationunknown5SUPPLYING
Cardinal Health 107, LLCunknown5SUPPLYING
Medical Purchasing Solutions, LLCunknown4SUPPLYING
Civica, Inc.unknown4SUPPLYING
Asclemed USA, Inc.unknown4SUPPLYING
Camber Pharmaceuticals, Inc.unknown4SUPPLYING
REMEDYREPACK INC.repackager4SUPPLYING
Sagent Pharmaceuticalsunknown3SUPPLYING
Henry Schein Inc.unknown3SUPPLYING
A-S Medication Solutionsunknown3SUPPLYING
NorthStar Rx LLCunknown3SUPPLYING

+ 9 more labelers

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Oct 1, 2025
    RECALLRecall (Class II): Ketorolac Tromethamine Injection, USP, 60 mg/2 mL (30 mg/mL), 2 mL Single-Dose Vial, For Intramuscular Use Only, Rx onl…

    Presence of Particulate Matter: Particulate matter identified as glass — Recalling firm: Aspiro Pharma Limited — Nationwide within the United States

  • Dec 23, 2020
    RECALLRecall (Class I): Ketorolac Tromethamine Injection, USP, 30 mg per mL, packaged in 1 mL Single Dose Vials (NDC 63323-162-00); 25 x 1 mL S…

    Presence of Particulate Matter - found in reserve sample vials at the firm. — Recalling firm: Fresenius Kabi USA, LLC — Nationwide USA and Puerto Rico

  • Dec 17, 2020
    RECALLRecall (Class II): Ketorolac Tromethamine Injection, USP, 60 mg per 2 mL (30 mg per mL), packaged in 2 mL Single Dose Vial, Rx only, Frese…

    Presence of Particulate Matter - found in reserve sample vials at the firm. — Recalling firm: Fresenius Kabi USA, LLC — USA Nationwide and Puerto Rico

  • Apr 20, 2020
    RECALLRecall (Class II): Ketorolac Tromethamine Injection, USP, 60 mg per 2 mL (30 mg per mL), packaged in 2 mL Single Dose Vials (NDC 63323-162…

    Presence of Particulate Matter - found in reserve sample vials at the firm. — Recalling firm: Fresenius Kabi USA, LLC — USA Nationwide and Puerto Rico

  • Apr 20, 2020
    RECALLRecall (Class I): Ketorolac Tromethamine Injection, USP, 30 mg per mL, packaged in 1 mL Single Dose Vials (NDC 63323-162-00); 25 x 1 mL S…

    Presence of Particulate Matter - found in reserve sample vials at the firm. — Recalling firm: Fresenius Kabi USA, LLC — USA Nationwide and Puerto Rico

  • Apr 30, 2019
    RECALLRecall (Class II): Ketorolac Tromethamine Injection, USP, 60 mg per 2 mL (30 mg per mL), 2 mL Vials, Rx only, Mfd. for Sagent Pharmaceuti…

    Lack of Sterility Assurance: Microbial growth detected during a routine simulation of the manufacturing process, which represents the potential introduction of microorganisms into the products. — Recalling firm: Sagent Pharmaceuticals Inc — Nationwide USA and Puerto Rico

  • Jun 6, 2018
    SHORTAGEDrug shortage: Ketorolac Tromethamine Injection (Baxter Healthcare)

    Ketorolac Tromethamine Injection — reported in shortage by Baxter Healthcare. Therapeutic category: Analgesia/Addiction.

  • Mar 26, 2018
    SHORTAGEDrug shortage: Ketorolac Tromethamine Injection (Sagent Pharmaceuticals)

    Ketorolac Tromethamine Injection — reported in shortage by Sagent Pharmaceuticals. Therapeutic category: Analgesia/Addiction.

  • Mar 26, 2018
    SHORTAGEDrug shortage: Ketorolac Tromethamine Injection (Hospira, Inc., a Pfizer Company)

    Ketorolac Tromethamine Injection — reported in shortage by Hospira, Inc., a Pfizer Company. Therapeutic category: Analgesia/Addiction.

  • Mar 23, 2018
    SHORTAGEDrug shortage: Ketorolac Tromethamine Injection (Gland Pharma Limited)

    Ketorolac Tromethamine Injection — reported in shortage by Gland Pharma Limited. Therapeutic category: Analgesia/Addiction.

  • Mar 23, 2018
    SHORTAGEDrug shortage: Ketorolac Tromethamine Injection (Fresenius Kabi USA, LLC)

    Ketorolac Tromethamine Injection — reported in shortage by Fresenius Kabi USA, LLC. Therapeutic category: Analgesia/Addiction.

  • Jun 30, 2015
    RECALLRecall (Class II): KETOROLAC Tromethamine Inj., USP, 30 mg (30 mg/mL), 1 mL Fill, Single-dose Vials, I.V/I.M. USE, Hospira, Inc., Lake For…

    Crystallization; identified as calcium salt of Ketorolac — Recalling firm: Hospira Inc. — Nationwide, Puerto Rico, Guam, Canada and Singapore

  • Jun 30, 2015
    RECALLRecall (Class II): KETOROLAC Tromethamine Inj., USP, 60 mg (30 mg/mL), 2 mL Fill Single-dose Vials, I.V/I.M. USE, Hospira, Inc., Lake Fore…

    Crystallization; identified as calcium salt of Ketorolac — Recalling firm: Hospira Inc. — Nationwide, Puerto Rico, Guam, Canada and Singapore

  • Jan 23, 2015
    RECALLRecall (Class II): KETOROLAC Tromethamine Inj., USP, 60 mg (30 mg/mL), 2 mL Fill Single-dose Vials, I.V/I.M. USE, Hospira, Inc., Lake Fore…

    Crystallization — Recalling firm: Hospira Inc. — U.S. Nationwide and International: Guam and Singapore.

  • Jan 23, 2015
    RECALLRecall (Class II): KETOROLAC Tromethamine Inj., USP, 30 mg (30 mg/mL), 1 mL Fill, Single-dose Vials, I.V/I.M. USE, Hospira, Inc., Lake For…

    Crystallization — Recalling firm: Hospira Inc. — U.S. Nationwide and International: Guam and Singapore.

  • Oct 6, 2014
    RECALLRecall (Class II): Ketorolac Tromethamine Inj., USP, 60 mg (30 mg/mL), 2 mL Single-dose Fliptop Vial, packaged in 25 Units per carton, Rx …

    Temperature Abuse: Products experienced uncontrolled temperature excursions during transit. — Recalling firm: Hospira Inc. — Distribution limited to one shipment to The Harvard Drug Group, Livonia, MI for the lots of Vancomycin 500 mg, Ketorola…

  • Oct 3, 2014
    RECALLRecall (Class II): Ketorolac Tromethamine INJECTION, USP, 30 mg per mL, a) 1 mL vial (NDC 25021-701-01) b) 2 mL vial (NDC 25021-701-02), R…

    Incorrect or Missing Lot and/or Exp Date: Ketorolac Tromethamine Injection, is being recalled as a result of labeling the product with the incorrect expiration date. — Recalling firm: Sagent Pharmaceuticals Inc — Nationwide and Puerto Rico

  • Aug 12, 2013
    RECALLRecall (Class II): Ketorolac Tromethamine Inj., USP, 30 mg vial, Rx only, Hospira, Inc., Lake Forest, IL 60045 USA, NDC 0409-3795-01

    Lack of Assurance of Sterility: Either a loose crimp or no crimp was applied to the fliptop vials. — Recalling firm: Hospira, Inc. — Naitonwide